25 reports

Cardiovascular drug delivery systems are also included in the report, such as nanoparticle-mediated drug delivery, gene therapy and cell therapy, among others.

  • Cardiovascular Drug
  • Therapy
  • World

APAC is one of the most attractive regions for the heart failure drugs market.

  • Beta-Blocker
  • Cardiovascular Drug
  • Amgen Inc.
  • AstraZeneca PLC
  • Novartis AG

The introduction of advanced pain free drug delivery technologies is promoting the use of musculoskeletal drugs.

  • Cardiovascular Drug
  • Market Size
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

It develops drugs and drug delivery systems for the treatment of PD and other diseases affecting the CNS.

  • Cardiovascular Drug
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

The cardiovascular drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Cardiovascular Drug
  • China
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Tasly Pharmaceutical Co., Ltd.

THE HYPERTENSION DRUGS INDUSTRY IS ONE OF KEY SECTORS OF CHINESE INDUSTRY AND HAS BECOME MORE AND MORE IMPORTANT.

  • Cardiovascular Drug
  • China
  • AstraZeneca China Inc.
  • Hangzhou MSD Pharmaceutical Co., Ltd
  • Sanofi-Synthelabo Inc.
  • Product recalls and regulatory issues
  • Vendor landscape

Mylan' s lead competitor Sanofi was forced to exit the market in 2015 due to a potential inaccurate drug delivery from its Auvi-Q and Allerject.

  • Cardiovascular Drug
  • World
  • Impax Laboratories, Inc.
  • Lincoln Medical, Ltd.
  • Mylan Inc.

This sharply curtails the delivery of oxygen and nutrients to vital organs.

  • Cardiovascular Drug
  • China
  • Demand
  • Supply
  • Tasly Pharmaceutical Co., Ltd.

The Group Company has been mainly developing modern Chinese medicine and new chemical drug delivery system, having a dominant position in drugs for CCVD (Cardiac Cerebral Vascular Disease), children and women, striving to be the top brand of CCD (Cardiac Cerebral Disease)

  • Cardiovascular Drug
  • China
  • Demand
  • AstraZeneca China Inc.
  • Sanofi-Synthelabo Inc.

SUDA Develops drug delivery technologies in Australia.

  • Cardiovascular Drug
  • Actelion Ltd
  • AstraZeneca PLC
  • Daiichi Sankyo Company
  • Sanofi S.A.

SHE ALSO PARTICIPATED IN THE DEVELOPMENT AND PATENTING OF A NOVEL NANOPARTICLE-BASED SYSTEM FOR DRUG DELIVERY, WHICH LED HER TO CO-FOUND TECREA LTD., A SPIN-OFF COMPANY BASED IN LONDON' S BIOSCIENCE INNOVATION CENTRE.

  • Cardiovascular Drug
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company
  • Pfizer Inc.

Drug Safety; ##(##): ##-##.

  • Cardiovascular Drug
  • Market Size
  • Daiichi Sankyo Company
  • Merck & Co., Inc.
  • Novartis AG
  • 12/13/2017: Suda Reveals New Data Supporting Use of Anagrelide to Treat Cancer
  • 07/12/2018: Suda Pharmaceuticals: Anagrelide Update

The company uses OroMist oromucosal drug delivery technology to develop pharmaceutical products.

  • Cardiovascular Drug
  • Australia
  • Company
  • Supply
  • Suda Ltd
  • 5. All the trials included are unique trials.

The investigational product is a transdermal formulation developed using Hisamitsu' s TDDS (Transdermal Drug Delivery System) technology and expected to realize its long-lasting effect by means of maintaining a stable blood concentration.

  • Cardiovascular Drug
  • Clinical Trial
  • Pharmaceutical
  • Psychotic Disorder
  • World
  • 12/13/2017: Suda Reveals New Data Supporting Use of Anagrelide to Treat Cancer
  • 07/12/2018: Suda Pharmaceuticals: Anagrelide Update

The company uses OroMist oromucosal drug delivery technology to develop pharmaceutical products.

  • Cardiovascular Drug
  • Australia
  • Company
  • Supply
  • Suda Ltd

Adamis intends to pursue a number of other important drug candidates. ##M will supply the drug delivery tape for the platform to Adamis under a separate supply agreement.

  • Cardiovascular Drug
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Adamis Pharmaceuticals Corporation
  • BMS-986179 - DRUG PROFILE

Food and Drug Administration (FDA) for the initiation of a Phase ## clinical study of TJ## in patients with advanced solid tumors.

  • Cardiovascular Drug
  • Medical Biotechnology
  • United States
  • Company Operations
  • Product Initiative
  • Jan 10, 2017: MonoSol Rx to Initiate Human Proof-of-Concept Study of Epinephrine Sublingual Soluble Film
  • ANAPHYLAXIS - PIPELINE BY AQUESTIVE THERAPEUTICS INC, H2 2018

The drug candidate acts by targeting Fc gamma receptor type ## (FcgR##).

  • Cardiovascular Drug
  • Therapy
  • United States
  • World
  • Product Initiative
  • ANAPHYLAXIS - PIPELINE BY INSYS THERAPEUTICS INC, H1 2018
  • ANAPHYLAXIS - PIPELINE BY AQUESTIVE THERAPEUTICS, H1 2018

The drug candidate acts by targeting Fc gamma receptor type ## (FcgR##).

  • Cardiovascular Drug
  • Therapy
  • United States
  • World
  • Product Initiative
  • BMS-986179 - DRUG PROFILE
  • 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Product Development Milestones

HALOZYME' S PROPRIETARY ENHANZE® DRUG-DELIVERY TECHNOLOGY IS BASED ON ITS PATENTED RECOMBINANT HUMAN HYALURONIDASE ENZYME (RHUPH##).

  • Cardiovascular Drug
  • Oncology
  • Pharmaceutical
  • United States
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Cardiovascular Drug
  • Neurological Disorder
  • Neurology
  • World
  • Shire plc

The nature of enhancement may involve drug delivery, manufacturing, or reformulation technology.

  • Anti-Infective
  • Cardiovascular Drug
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation

The company concentrates on drug delivery, biotherapeutics, and small molecule discovery.

  • Cardiovascular Drug
  • Hypertension
  • United States
  • World
  • Product Initiative
  • IDIOPATHIC (ESSENTIAL) HYPERTENSION - PIPELINE BY SUN PHARMA ADVANCED RESEARCH COMPANY LTD., H1 2016

The company' s activities include drug delivery, biotherapeutics, and small molecule discovery.

  • Cardiovascular Drug
  • Hypertension
  • Pharmaceutical
  • United States
  • Company Operations
  • lists the co-development deals that occurred between 2006 and 2015.
  • 4.11 OVERVIEW OF MARKETED PRODUCTS

Innovation in the PD market has so far been focused on new drug delivery approaches to achieve continuous drug release.

  • Cardiovascular Drug
  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Therapy